Qsemble Capital Management LP Lowers Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Qsemble Capital Management LP reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 48.4% during the first quarter, Holdings Channel.com reports. The fund owned 9,017 shares of the company’s stock after selling 8,465 shares during the quarter. Qsemble Capital Management LP’s holdings in Henry Schein were worth $681,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of HSIC. Arizona State Retirement System grew its stake in Henry Schein by 0.4% in the fourth quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock worth $2,717,000 after purchasing an additional 149 shares in the last quarter. Empirical Finance LLC grew its position in shares of Henry Schein by 3.5% during the 1st quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock worth $360,000 after buying an additional 160 shares in the last quarter. Keene & Associates Inc. grew its position in shares of Henry Schein by 4.0% during the 1st quarter. Keene & Associates Inc. now owns 4,505 shares of the company’s stock worth $340,000 after buying an additional 175 shares in the last quarter. Wahed Invest LLC increased its stake in shares of Henry Schein by 9.2% during the fourth quarter. Wahed Invest LLC now owns 2,222 shares of the company’s stock valued at $168,000 after buying an additional 187 shares during the period. Finally, Crossmark Global Holdings Inc. raised its holdings in shares of Henry Schein by 1.5% in the fourth quarter. Crossmark Global Holdings Inc. now owns 13,090 shares of the company’s stock valued at $991,000 after acquiring an additional 197 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. UBS Group dropped their target price on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating on the stock in a report on Wednesday, May 8th. Piper Sandler reiterated an “overweight” rating and set a $86.00 price objective on shares of Henry Schein in a research note on Friday, June 21st. Barrington Research reissued an “outperform” rating and issued a $92.00 price objective on shares of Henry Schein in a research note on Friday, July 5th. Finally, Evercore ISI lowered their target price on Henry Schein from $75.00 to $72.00 and set an “in-line” rating for the company in a report on Tuesday, July 9th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and five have given a buy rating to the company. According to MarketBeat.com, Henry Schein has a consensus rating of “Hold” and an average price target of $80.73.

Henry Schein Stock Up 4.8 %

Shares of Henry Schein stock traded up $3.23 during trading on Wednesday, reaching $70.82. The company’s stock had a trading volume of 696,900 shares, compared to its average volume of 1,076,768. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The company has a 50-day simple moving average of $68.53 and a two-hundred day simple moving average of $72.07. The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47. The company has a market cap of $9.07 billion, a price-to-earnings ratio of 24.11, a P/E/G ratio of 1.62 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, May 7th. The company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.01 by $0.09. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The company had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.21 billion. During the same period last year, the business posted $1.21 earnings per share. The firm’s revenue was up 3.7% compared to the same quarter last year. As a group, equities analysts forecast that Henry Schein, Inc. will post 5.16 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.